Correspondence 0001493152-23-021035 from Bone Biologics Corp (BBLG)
Bone Biologics Corp
Date: June 13, 2023 · CIK: 0001419554 · Accession: 0001493152-23-021035
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-271558
Letter
BONE BIOLOGICS CORPORATION
Burlington Woods Drive, Suite 100
Burlington, MA 01803
June 13, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
F. Street, N.E.
Washington, D.C. 20549
Re: Bone Biologics Corporation
Registration Statement on Form S-1
Filed June 13, 2023
File No. 333-271558
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Bone Biologics Corporation, a Delaware corporation, respectfully requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective at 5:30 p.m., Eastern Time, on Wednesday, June 14, 2023 or as soon thereafter as is practicable. Please call our CFO, Deina Walsh at 585-775-7014 to provide notice of effectiveness.
Very
truly yours,
BONE
BIOLOGICS CORPORATION
Show Raw Text
CORRESP
1
filename1.htm
BONE
BIOLOGICS CORPORATION
2
Burlington Woods Drive, Suite 100
Burlington,
MA 01803
June
13, 2023
VIA
EDGAR
Securities
and Exchange Commission
Division
of Corporation Finance
100
F. Street, N.E.
Washington,
D.C. 20549
Re:
Bone Biologics
Corporation
Registration
Statement on Form S-1
Filed June
13, 2023
File
No. 333-271558
Ladies
and Gentlemen:
In
accordance with Rule 461 under the Securities Act of 1933, as amended, Bone Biologics Corporation, a Delaware corporation, respectfully
requests that the effective date of the above-referenced Registration Statement be accelerated so that the same will become effective
at 5:30 p.m., Eastern Time, on Wednesday, June 14, 2023 or as soon thereafter as is practicable. Please call our CFO, Deina Walsh at
585-775-7014 to provide notice of effectiveness.
Very
truly yours,
BONE
BIOLOGICS CORPORATION
By:
/s/
Jeffrey Frelick
Jeffrey
Frelick
Chief Executive
Officer